Veloxis_logo - Color - Screen.png
Veloxis Increases Share Capital in Connection with Exercise of Warrants
December 02, 2019 16:57 ET | Veloxis Pharmaceuticals A/S
Company Release no. 19/2019 To: NASDAQ Copenhagen A/S                                                       Copenhagen, Denmark, 2 December 2019 Veloxis Increases Share Capital in Connection with...
Veloxis_logo - Color - Screen.png
Veloxis to Host Conference Call Following Asahi Kasei Group’s Announcement of a Recommended Conditional Voluntary Public Offer for Veloxis
November 25, 2019 02:48 ET | Veloxis Pharmaceuticals A/S
Investor News no. 05/2019 To: NASDAQ Copenhagen A/S                                                   Copenhagen, Denmark, 25 November 2019 Veloxis to Host Conference Call...
Veloxis_logo - Color - Screen.png
Asahi Kasei Group offentliggør anbefalet betinget, frivilligt offentligt købstilbud på Veloxis
November 25, 2019 02:29 ET | Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 18/2019 Til: NASDAQ Copenhagen A/S   København, Danmark, 25. november 2019 Asahi Kasei Group offentliggør anbefalet betinget, frivilligt offentligt købstilbud på Veloxis...
Veloxis_logo - Color - Screen.png
Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis
November 25, 2019 02:29 ET | Veloxis Pharmaceuticals A/S
Company Release no. 18/2019 To: NASDAQ Copenhagen A/S  Copenhagen, Denmark, 25 November 2019 Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for...
Veloxis_logo - Color - Screen.png
Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2019
November 12, 2019 10:23 ET | Veloxis Pharmaceuticals A/S
Company Release no. 17/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 12 November 2019   Veloxis Pharmaceuticals Announces Financial...
Veloxis_logo - Color - Screen.png
Veloxis Increases Outlook for 2019 Based on Continued Strong Performance
October 30, 2019 19:13 ET | Veloxis Pharmaceuticals A/S
Company Release no. 16/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 31 October 2019   Veloxis Increases Outlook for 2019 Based on...
Veloxis_logo - Color - Screen.png
Veloxis Increases Share Capital in Connection with Exercise of Warrants
September 05, 2019 16:53 ET | Veloxis Pharmaceuticals A/S
Company Release no. 15/2019 To: NASDAQ Copenhagen A/S                                                       Copenhagen, Denmark, 05 September 2019 Veloxis Increases Share Capital in Connection...
Veloxis_logo - Color - Screen.png
Veloxis Increases Share Capital in Connection with Exercise of Warrants
August 23, 2019 16:38 ET | Veloxis Pharmaceuticals A/S
Company Release no. 14/2019 To: NASDAQ Copenhagen A/S                                                       Copenhagen, Denmark, 23 August 2019 Veloxis Increases Share Capital in Connection...
Veloxis_logo - Color - Screen.png
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
August 13, 2019 17:48 ET | Veloxis Pharmaceuticals A/S
Company Release no. 13/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 13 August 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under...
Veloxis_logo - Color - Screen.png
Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2019
August 08, 2019 11:47 ET | Veloxis Pharmaceuticals A/S
Company Release no. 12/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 08 August 2019 Veloxis Pharmaceuticals Announces...